{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:24:58Z","timestamp":1787207098643,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human endogenous retroviruses (HERVs) may modulate antitumor immunity and prognosis in pancreatic cancer (PC), but reported findings remain heterogeneous.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted according to PRISMA guidelines. PubMed\/MEDLINE and grey literature were searched for studies reporting HERV expression in PC. Extracted data included HERV family and genomic region, detection methods, biological specimens, immune correlations, clinicopathologic associations, and survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven studies were included, reporting 1,085 PC cases among 9,241 cancer patients. HERV-H was evaluated in 6 studies, HERV-K in 3, and 2 studies did not specify family. Elements included env sequences (3 studies), envelope proteins (2), LTR sequences (6), and LTR-derived proteins (HHLA2 (5). Detection methods comprised RNA-seq (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097 studies), PCR\/qPCR (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097), immunohistochemistry (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096), western blot (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094), and ELISA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094). HERV detection ranged from 16.7% to ~\u200980%, varying with the sequence and laboratory method. Immune correlations were described in 7 studies, including associations with CD8\u207a T-cell infiltration, cytokines (IL-2, TNF-\u03b1, IFN-\u03b3), PD-1\/PD-L1, and anti-HERV antibodies. Overall survival was reported in 6 studies, with both adverse (HR 1.26\u20132.24) and favourable (HR 0.47\u20130.66) associations reported, particularly for HERV-H derived LTR products (HHLA2).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HERVs exhibit frequent, target-dependent expression patterns that trigger proinflammatory activation. Within these families, HERV-H derived LTR elements, specifically HHLA2, demonstrate the most consistent correlation with increased T-cell infiltration and favorable survival, supporting their potential as prognostic biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16373-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:52:33Z","timestamp":1787205153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7701-9038","authenticated-orcid":false,"given":"Paula Iuliana","family":"Toma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentia Nicoleta","family":"Gales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Ghiringhelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda","family":"Trandafir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca Ioana","family":"Budea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Mihaela","family":"Ilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"6822","key":"16373_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860\u2013921. doi:10.1038\/35057062 PubMed PMID: 11237011.","journal-title":"Nature"},{"issue":"4","key":"16373_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg3199","volume":"13","author":"C Feschotte","year":"2012","unstructured":"Feschotte C, Gilbert C. Endogenous viruses: insights into viral evolution and impact on host biology. Nat Rev Genet. 2012;13(4):283\u201396. https:\/\/doi.org\/10.1038\/nrg3199 . PubMed PMID: 22421730.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"16373_CR3","doi-asserted-by":"publisher","first-page":"14572","DOI":"10.1073\/pnas.0404838101","volume":"101","author":"N Bannert","year":"2004","unstructured":"Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A. 2004;101(2):14572\u20139. https:\/\/doi.org\/10.1073\/pnas.0404838101 . PubMed PMID: 15310846; PubMed Central PMCID: PMC521986.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16373_CR4","doi-asserted-by":"publisher","unstructured":"Grandi N, Tramontano E. Front Immunol. 2018;9:2039. https:\/\/doi.org\/10.3389\/fimmu. 2018.02039 PubMed PMID: 30250470; PubMed Central PMCID: PMC6139349. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses.","DOI":"10.3389\/fimmu"},{"issue":"2","key":"16373_CR5","doi-asserted-by":"publisher","first-page":"e2025","DOI":"10.1002\/rmv.2025","volume":"29","author":"M Zhang","year":"2019","unstructured":"Zhang M, Liang JQ, Zheng S. Expressional activation and functional roles of human endogenous retroviruses in cancers. Rev Med Virol. 2019;29(2):e2025. :10.1002\/rmv.2025 PubMed PMID: 30614117; PubMed Central PMCID: PMC6590502.","journal-title":"Rev Med Virol"},{"key":"16373_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-3-642","volume":"148","author":"E Larsson","year":"1989","unstructured":"Larsson E, Kato N, Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol. 1989;148:115\u201332. https:\/\/doi.org\/10.1007\/978-3-642. 74700-7_4 PubMed PMID: 2684548.","journal-title":"Curr Top Microbiol Immunol"},{"key":"16373_CR7","doi-asserted-by":"publisher","first-page":"1439292","DOI":"10.3389\/fcimb.2024.1439292","volume":"14","author":"C Bao","year":"2024","unstructured":"Bao C, Gao Q, Xiang H, Shen Y, Chen Q, Gao Q, et al. Human endogenous retroviruses and exogenous viral infections. Front Cell Infect Microbiol. 2024;14:1439292. https:\/\/doi.org\/10.3389\/fcimb.2024.1439292 . PubMed PMID: 39397863; PubMed Central PMCID: PMC11466896.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"16373_CR8","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1007\/s11033-023-08658-0","volume":"50","author":"M Gholami Barzoki","year":"2023","unstructured":"Gholami Barzoki M, Shatizadeh Malekshahi S, Heydarifard Z, Mahmodi MJ, Soltanghoraee H. The important biological roles of Syncytin-1 of human endogenous retrovirus W (HERV-W) and Syncytin-2 of HERV-FRD in the human placenta development. Mol Biol Rep. 2023;50(9):7901\u20137. https:\/\/doi.org\/10.1007\/s11033-023-08658-0 . PubMed PMID: 37421503.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"16373_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/pathogens12020162","volume":"12","author":"E Russ","year":"2023","unstructured":"Russ E, Iordanskiy S. Endogenous Retroviruses as Modulators of Innate Immunity. Pathogens. 2023;12(2):162. doi:10.3390\/pathogens12020162 PubMed PMID: 36839434; PubMed Central PMCID: PMC9963469.","journal-title":"Pathogens"},{"issue":"3","key":"16373_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0558-9 . PubMed PMID: 32025001; PubMed Central PMCID: PMC8076016.","journal-title":"Nat Genet"},{"issue":"4","key":"16373_CR11","doi-asserted-by":"publisher","first-page":"nwae034","DOI":"10.1093\/nsr\/nwae034","volume":"11","author":"J Yu","year":"2024","unstructured":"Yu J, Qiu P, Ai J, Liu B, Han GZ, Zhu F, et al. Endogenous retrovirus activation: potential for immunology and clinical applications. Natl Sci Rev. 2024;11(4):nwae034. https:\/\/doi.org\/10.1093\/nsr\/nwae034 . PubMed PMID: 38495812; PubMed Central PMCID: PMC10941811.","journal-title":"Natl Sci Rev"},{"issue":"1","key":"16373_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1128\/MMBR.00033-07","volume":"72","author":"C Voisset","year":"2008","unstructured":"Voisset C, Weiss RA, Griffiths DJ. Human RNA rumor viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev. 2008;72(1):157\u201396. https:\/\/doi.org\/10.1128\/MMBR.00033-07. table of contents.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"16373_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cancers12030610","volume":"12","author":"V Alcazer","year":"2020","unstructured":"Alcazer V, Bonaventura P, Depil S. Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers. Cancers (Basel). 2020;12(3):610. doi:10.3390\/cancers12030610 PubMed PMID: 32155827; PubMed Central PMCID: PMC7139688.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"16373_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16373_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1158\/0008-5472.CAN-16-2452","volume":"77","author":"EA Collisson","year":"2017","unstructured":"Collisson EA, Olive KP. Pancreatic Cancer: Progress and Challenges in a Rapidly Moving Field. Cancer Res. 2017;77(5):1060\u20132. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2452 . PubMed PMID: 28209609.","journal-title":"Cancer Res"},{"issue":"2","key":"16373_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.canlet.2007.01.003","volume":"252","author":"FH Schmitz-Winnenthal","year":"2007","unstructured":"Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, et al. Potential target antigens for immunotherapy in human pancreatic cancer. Cancer Lett. 2007;252(2):290\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2007.01.003 . PubMed PMID: 17320278.","journal-title":"Cancer Lett"},{"issue":"19","key":"16373_CR17","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1158\/1078-0432.CCR-17-0001","volume":"23","author":"M Li","year":"2017","unstructured":"Li M, Radvanyi L, Yin B, Rycaj K, Li J, Chivukula R, et al. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clin Cancer Res. 2017;23(19):5892\u2013911. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0001 . PubMed PMID: 28679769; PubMed Central PMCID: PMC5777511.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"16373_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/cas.13914","volume":"110","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang J, Chen W, Zhang Q, Wei T, Zhou Y, et al. B7-H5\/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. Cancer Sci. 2019;110(2):530\u20139. https:\/\/doi.org\/10.1111\/cas.13914 . PubMed PMID: 30548441; PubMed Central PMCID: PMC6361571.","journal-title":"Cancer Sci"},{"issue":"1","key":"16373_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12957-024-03409-2","volume":"22","author":"S Zhou","year":"2024","unstructured":"Zhou S, Wang Z, Zhao D, Fu Y, Zhang S, Wang Z, et al. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR\/MAPK\/ERK and mTOR\/AKT pathway. World J Surg Oncol. 2024;22(1):133. https:\/\/doi.org\/10.1186\/s12957-024-03409-2 . PubMed PMID: 38762741; PubMed Central PMCID: PMC11102221.","journal-title":"World J Surg Oncol"},{"key":"16373_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n. 71 PubMed PMID: 33782057; PubMed Central PMCID: PMC8005924.","journal-title":"BMJ"},{"issue":"7","key":"16373_CR21","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/ijc.22826","volume":"121","author":"N Wentzensen","year":"2007","unstructured":"Wentzensen N, Coy JF, Knaebel H, Linnebacher M, Wilz B, Gebert J, et al. Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers. Intl J Cancer. 2007;121(7):1417\u201323. https:\/\/doi.org\/10.1002\/ijc.22826.","journal-title":"Intl J Cancer"},{"issue":"S3","key":"16373_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1245\/s10434-014-4293-2","volume":"22","author":"JT Byers","year":"2015","unstructured":"Byers JT, Paniccia A, Kaplan J, Koenig M, Kahn N, Wilson L, et al. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer. Ann Surg Oncol. 2015;22(S3):1574\u20139. https:\/\/doi.org\/10.1245\/s10434-014-4293-2.","journal-title":"Ann Surg Oncol"},{"key":"16373_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.canlet.2018.11.007","volume":"442","author":"H Yan","year":"2019","unstructured":"Yan H, Qiu W, De Koehne AK, Wei JS, Tu M, Xi CH, et al. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Lett. 2019;442:333\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2018.11.007.","journal-title":"Cancer Lett"},{"issue":"8","key":"16373_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41416-020-0755-4","volume":"122","author":"PPC Boor","year":"2020","unstructured":"Boor PPC, Sideras K, Biermann K, Hosein Aziz M, Levink IJM, Mancham S, et al. HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis. Br J Cancer. 2020;122(8):1211\u20138. https:\/\/doi.org\/10.1038\/s41416-020-0755-4.","journal-title":"Br J Cancer"},{"key":"16373_CR25","doi-asserted-by":"publisher","first-page":"1533740","DOI":"10.3389\/fimmu.2024.1533740","volume":"15","author":"Q Gong","year":"2025","unstructured":"Gong Q, Xu R. Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer. Front Immunol. 2025;15:1533740. https:\/\/doi.org\/10.3389\/fimmu.2024.1533740.","journal-title":"Front Immunol"},{"issue":"1","key":"16373_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-015-0142-6","volume":"7","author":"EA Gibb","year":"2015","unstructured":"Gibb EA, Warren RL, Wilson GW, Brown SD, Robertson GA, Morin GB, et al. Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma. Genome Med. 2015;7(1):22. https:\/\/doi.org\/10.1186\/s13073-015-0142-6.","journal-title":"Genome Med"},{"issue":"9","key":"16373_CR27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1158\/1535-7163.MCT-20-0094","volume":"19","author":"JT Topham","year":"2020","unstructured":"Topham JT, Titmuss E, Pleasance ED, Williamson LM, Karasinska JM, Culibrk L, et al. Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types. Mol Cancer Ther. 2020;19(9):1889\u201397. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0094.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"16373_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbrc.2009.03.058","volume":"382","author":"Q Liang","year":"2009","unstructured":"Liang Q, Ding J, Xu R, Xu Z, Zheng S. Identification of a novel human endogenous retrovirus and promoter activity of its 5\u2019 U3. Biochem Biophys Res Commun. 2009;382(2):468\u201372. https:\/\/doi.org\/10.1016\/j.bbrc.2009.03.058 . PubMed PMID: 19289097.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"16373_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-13-1349","volume":"74","author":"C Kudo-Saito","year":"2014","unstructured":"Kudo-Saito C, Yura M, Yamamoto R, Kawakami Y. Induction of immunoregulatory CD271\u2009+\u2009cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Res. 2014;74(5):1361\u201370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1349 . PubMed PMID: 24590808.","journal-title":"Cancer Res"},{"key":"16373_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fonc.2013.00246","volume":"3","author":"O Hohn","year":"2013","unstructured":"Hohn O, Hanke K, Bannert N. HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease. Front Oncol. 2013;3:246. https:\/\/doi.org\/10.3389\/fonc.2013.00246 . PubMed PMID: 24066280; PubMed Central PMCID: PMC3778440.","journal-title":"Front Oncol"},{"issue":"Pt 12","key":"16373_CR31","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1099\/vir.0.070631-0","volume":"95","author":"B Salmons","year":"2014","unstructured":"Salmons B, Lawson JS, G\u00fcnzburg WH. Recent developments linking retroviruses to human breast cancer: infectious agent, enemy within or both? J Gen Virol. 2014;95(Pt 12):2589\u201393. https:\/\/doi.org\/10.1099\/vir.0.070631-0 . PubMed PMID: 25217613.","journal-title":"J Gen Virol"},{"issue":"8","key":"16373_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/biology12081044","volume":"12","author":"A Morgan","year":"2023","unstructured":"Morgan A, Griffin M, Kameni L, Wan DC, Longaker MT, Norton JA. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Biology (Basel). 2023;12(8):1044. https:\/\/doi.org\/10.3390\/biology12081044 . PubMed PMID: 37626931; PubMed Central PMCID: PMC10451924.","journal-title":"Biology (Basel)"},{"key":"16373_CR33","doi-asserted-by":"publisher","unstructured":"Grabski DF, Hu Y, Sharma M, Rasmussen SK. Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology. J Surg Res. 2019;240:145\u201355. https:\/\/doi.org\/10.1016\/j.jss.2019.02.009","DOI":"10.1016\/j.jss.2019.02.009"},{"key":"16373_CR34","doi-asserted-by":"publisher","first-page":"103987","DOI":"10.1016\/j.ebiom.2022.103987","volume":"79","author":"H Ying","year":"2022","unstructured":"Ying H, Xu J, Zhang X, Liang T, Bai X. Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy. EBioMedicine. 2022;79:103987. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103987 . PubMed PMID: 35439678; PubMed Central PMCID: PMC9035628.","journal-title":"EBioMedicine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16373-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:52:34Z","timestamp":1787205154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16373-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16373"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16373-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the local legislation and institutional requirements.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1003"}}